Home LiteratureArticle Details
PMID: 9616207 Published · ppublish English Case Reports Journal Article

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

The Journal of clinical investigation ·Vol. 101 ·No. 11 ·1998-06-01 ·Pages 2364-9

Dorman SE, Holland SM

Abstract

IFN-gamma is critical in the immune response to mycobacterial infections, and deficits in IFN-gamma production and response have been associated with disseminated nontuberculous mycobacterial infections. Mutations in the IFN-gamma receptor ligand-binding chain (IFNgammaR1) have been shown to confer susceptibility to severe infection with nontuberculous mycobacteria. However, mutations in the IFN-gamma receptor signal-transducing chain (IFNgammaR2) have not been described. We describe a child with disseminated Mycobacterium fortuitum and M. avium complex infections and absent IFN-gamma signaling due to a mutation in the extracellular domain of IFNgammaR2. In vitro cytokine production by patient PBMCs showed 75% less PHA-induced IFN-gamma production than in normal cells, while patient PHA-induced TNF-alpha production was normal. The normal augmentation of TNF-alpha production when IFN-gamma was added to endotoxin was absent from patient cells. Expression of IFNgammaR1 was normal, but there was no phosphorylation of Stat1 in response to IFN-gamma stimulation. DNA sequence analysis of the gene for IFNgammaR2 showed a homozygous dinucleotide deletion at nucleotides 278 and 279, resulting in a premature stop codon in the protein extracellular domain. This novel gene defect associated with disseminated nontuberculous mycobacterial infection emphasizes the critical role that IFN-gamma plays in host defense against mycobacteria.

MeSH Terms
Disease Susceptibility Female Humans Infant, Newborn Interferon-gamma/biosynthesis Male Mutation Mycobacterium Infections/immunology Pregnancy Receptors, Interferon/genetics Signal Transduction
Chemicals
Receptors, Interferon interferon gamma receptor Interferon-gamma
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dorman S E
Laboratory of Host Defenses, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1886, USA.
Holland S M
References (28)
28 references, click to expand
  1. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  2. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
    J Clin Invest. 1997 Dec 1;100(11):2658-64 PMID: 9389728
  3. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  4. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.
    J Exp Med. 1993 Oct 1;178(4):1435-40 PMID: 8376946
  5. Disseminated tuberculosis in interferon gamma gene-disrupted mice.
    J Exp Med. 1993 Dec 1;178(6):2243-7 PMID: 8245795
  6. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
    J Exp Med. 1993 Dec 1;178(6):2249-54 PMID: 7504064
  7. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor.
    Cell. 1994 Mar 11;76(5):793-802 PMID: 8124716
  8. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major.
    J Exp Med. 1994 Apr 1;179(4):1367-71 PMID: 7908325
  9. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.
    N Engl J Med. 1994 May 12;330(19):1348-55 PMID: 7908719
  10. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
    Science. 1994 Jun 3;264(5164):1415-21 PMID: 8197455
  11. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?
    Lancet. 1995 Jan 14;345(8942):79-83 PMID: 7815885
  12. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.
    J Exp Med. 1995 Mar 1;181(3):961-71 PMID: 7869054
  13. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.
    J Exp Med. 1995 Jun 1;181(6):2069-76 PMID: 7759999
  14. Specific immunity to Listeria monocytogenes in the absence of IFN gamma.
    Immunity. 1995 Jul;3(1):109-17 PMID: 7621071
  15. Interaction between the components of the interferon gamma receptor complex.
    J Biol Chem. 1995 Sep 8;270(36):20915-21 PMID: 7673114
  16. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
    J Immunol. 1995 Oct 15;155(8):3964-71 PMID: 7561104
  17. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation.
    J Immunol. 1996 Jul 1;157(1):411-6 PMID: 8683146
  18. Role of interferon-gamma in immunity to herpes simplex virus.
    J Leukoc Biol. 1996 Oct;60(4):528-32 PMID: 8864138
  19. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
    J Immunol. 1996 Nov 1;157(9):4045-54 PMID: 8892638
  20. The structure of the gene for the second chain of the human interferon-gamma receptor.
    J Biol Chem. 1996 Nov 15;271(46):28947-52 PMID: 8910544
  21. IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice.
    J Immunol. 1996 Dec 1;157(11):4746-50 PMID: 8943375
  22. Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts.
    Infect Immun. 1996 Dec;64(12):5151-60 PMID: 8945559
  23. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.
    N Engl J Med. 1996 Dec 26;335(26):1941-9 PMID: 8960473
  24. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
    N Engl J Med. 1996 Dec 26;335(26):1956-61 PMID: 8960475
  25. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.
    Infect Immun. 1997 Feb;65(2):373-9 PMID: 9009285
  26. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency.
    Clin Infect Dis. 1997 May;24(5):982-4 PMID: 9142806
  27. The IFN gamma receptor: a paradigm for cytokine receptor signaling.
    Annu Rev Immunol. 1997;15:563-91 PMID: 9143700
  28. Molecular cloning and expression of the human interferon-gamma receptor.
    Cell. 1988 Oct 21;55(2):273-80 PMID: 2971451
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1998-06-01
Pages
2364-9
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508825
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com